Publications by authors named "Craig A Wilson"

Claim this Profile
K
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
Katherine G Garlo, William B White, George L Bakris, Faiez Zannad, Craig A Wilson

Clin J Am Soc Nephrol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Simon R Heller, Richard M Bergenstal, William B White, Stuart Kupfer, George L Bakris, Craig A Wilson

Diabetes Obes Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
William B White, Craig A Wilson, George L Bakris, Richard M Bergenstal, Christopher P Cannon

Hypertension· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.
William B White, Stuart Kupfer, Faiez Zannad, Cyrus R Mehta, Craig A Wilson

Diabetes Care· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetes.
Julio Rosenstock, Silvio E Inzucchi, Jochen Seufert, Penny R Fleck, Craig A Wilson

Diabetes Care· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies.
Richard E Pratley, Thérèse McCall, Penny R Fleck, Craig A Wilson, Qais Mekki

J Am Geriatr Soc· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Richard E Pratley, Jane E -B Reusch, Penny R Fleck, Craig A Wilson, Qais Mekki

Curr Med Res Opin· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study.
Ralph A DeFronzo, Penny R Fleck, Craig A Wilson, Qais Mekki,

Diabetes Care· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis